Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval

Simple item page
dc.contributor.authorTolman, Justin A.en_US
dc.contributor.authorFaulkner, Michele A.en_US
dc.contributor.cuauthorTolman, Justin A.en_US
dc.date.accessioned2014-06-27T13:37:36Z
dc.date.available2014-06-27T13:37:36Z
dc.date.issued2009en_US
dc.date.monthDecemberen_US
dc.date.year2009en_US
dc.description.issue18en_US
dc.description.pages3077-3089en_US
dc.description.volume10en_US
dc.identifier.citationTolman, Justin A. and Faulkner, Michele A. Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval. Expert opinion on pharmacotherapy. 2009, DEC. 10(18):3077-3089.en_US
dc.identifier.issn1465-6566en_US
dc.identifier.issn1744-7666en_US
dc.identifier.pmid19954276en_US
dc.identifier.urihttp://hdl.handle.net/10504/57604
dc.program.unitSchool of Pharmacy and Health Professionsen_US
dc.titleVigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approvalen_US
dc.title.workExpert Opinion on Pharmacotherapyen_US
dc.typeJournal Articleen_US
dc.url.link1http://dx.doi.org/10.1517/14656560903451690en_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Faculty Bibliography Database